UIA
MIRO

Ulland Investment Advisors’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Ulland Investment Advisors’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,000
Closed -$48K – 255
2022
Q2 		$48K Hold
12,000
– – 0.05% 101
2022
Q1 		$48K Buy
+12,000
New +$44.7K 0.04% 108

Other funds holding MIRO

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Ulland Investment Advisors's MIRO Position: Q3 2022 in Review

Ulland Investment Advisors sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q3 2022, closing a stake of 12,000 shares — an estimated $48K sold.

Ulland Investment Advisors first reported a position in MIRO in Q1 2022 and held it in 2 quarters. The position peaked at $48K in Q2 2022. 22 funds tracked by Wall St. Rank hold MIRO as of Q3 2022.

  • Ulland Investment Advisors reported no remaining Miromatrix Medical Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ulland Investment Advisors sold 12,000 Miromatrix Medical Inc. Common Stock shares in Q3 2022, an estimated $48K.
  • Ulland Investment Advisors first reported a position in Miromatrix Medical Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Ulland Investment Advisors's Miromatrix Medical Inc. Common Stock position peaked at $48K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q3 2022.

Based on Ulland Investment Advisors's 13F filing for Q3 2022, filed 12 Oct 2022.